Ziprasidone

Cat. No.: OB0225LY-0109

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by LC-MS.

Size:

INQUIRY Datasheet MSDS

Product Overview

Description: Ziprasidone is a united 5-HT (serotonin) and dopamine receptor antagonist with antipsychotic activity.

Synonym: Geodon; Zeldox; CP-88059; 146939-27-7; 5-[2-[4-(1,2-Benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one; 2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-; 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one; 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one

CAS No.: 146939-27-7

Compound CID: 60854

Formula: C₂₁H₂₁ClN₄OS

Formula Weight: 412.94

Specification

Relative Density: 0.8 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Ziprasidone plays a role in research on alleviating psychosis, mood swings and manic symptoms.

Library Information

Targets: Histamine receptor family; 5-HT receptor family; Adrenergic receptor family; Dopamine receptor family; Monoamine transporter

Receptors: 5-HT transporter; 5-HT1A; 5-HT1B; 5-HT1D; 5-HT2A; 5-HT2C; 5-HT6; 5-HT7; D1; D2; D3; H1 receptor; Norepinephrine transporter (NET); α1A-Adrenergic receptor; α2A-Adrenergic receptor

Pathways: GPCR/G protein; Immunology/Inflammation; Neuronal signaling

Plate Number: AOCL-2

Plate Location: d2

Empty Location: a1-h1; a12-h12

Container: 96-well plate

Formulation: 10 mM DMSO

DMSO Max Solubility: 13.5 mg/mL; 32.69 mM

Related Products

Inquiry